![Pan-HSV-2 IgG levels correlate with protection against vaginal HSV-2... | Download Scientific Diagram Pan-HSV-2 IgG levels correlate with protection against vaginal HSV-2... | Download Scientific Diagram](https://www.researchgate.net/profile/Joshua-Geltz/publication/237098655/figure/fig4/AS:299460597960708@1448408378293/Pan-HSV-2-IgG-levels-correlate-with-protection-against-vaginal-HSV-2-challenge-in-guinea.png)
Pan-HSV-2 IgG levels correlate with protection against vaginal HSV-2... | Download Scientific Diagram
![Characterization of the Interaction between the Herpes Simplex Virus Type I Fc Receptor and Immunoglobulin G* - Journal of Biological Chemistry Characterization of the Interaction between the Herpes Simplex Virus Type I Fc Receptor and Immunoglobulin G* - Journal of Biological Chemistry](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/6e88be73-bee3-48d1-a1a4-f1f418d61957/gr3_lrg.jpg)
Characterization of the Interaction between the Herpes Simplex Virus Type I Fc Receptor and Immunoglobulin G* - Journal of Biological Chemistry
A Herpes Simplex Virus 2 (HSV-2) Glycoprotein D-expressing Nonreplicating Dominant-Negative HSV-2 Virus Vaccine Is Superior to a gD2 Subunit Vaccine against HSV-2 Genital Infection in Guinea Pigs | PLOS ONE
![Herpes Simplex Virus Type 2 Glycoprotein D Inhibits NF-κB Activation by Interacting with p65 | The Journal of Immunology Herpes Simplex Virus Type 2 Glycoprotein D Inhibits NF-κB Activation by Interacting with p65 | The Journal of Immunology](https://www.jimmunol.org/content/jimmunol/206/12/2852/F1.large.jpg)
Herpes Simplex Virus Type 2 Glycoprotein D Inhibits NF-κB Activation by Interacting with p65 | The Journal of Immunology
![Enhanced Therapeutic Efficacy of a Novel Oncolytic Herpes Simplex Virus Type 2 Encoding an Antibody Against Programmed Cell Death 1: Molecular Therapy - Oncolytics Enhanced Therapeutic Efficacy of a Novel Oncolytic Herpes Simplex Virus Type 2 Encoding an Antibody Against Programmed Cell Death 1: Molecular Therapy - Oncolytics](https://www.cell.com/cms/attachment/dbfa3864-8ca3-4e9e-b9b3-087f0cb6364c/gr1_lrg.jpg)
Enhanced Therapeutic Efficacy of a Novel Oncolytic Herpes Simplex Virus Type 2 Encoding an Antibody Against Programmed Cell Death 1: Molecular Therapy - Oncolytics
![Clinical variability of recurrent oral HSV‐1 infection with a high level of serum IgG antibody: Three case reports - Zakiawati - 2021 - Clinical Case Reports - Wiley Online Library Clinical variability of recurrent oral HSV‐1 infection with a high level of serum IgG antibody: Three case reports - Zakiawati - 2021 - Clinical Case Reports - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/3841b6e2-4b1a-40d8-96e3-524372481f25/ccr34735-fig-0006-m.jpg)
Clinical variability of recurrent oral HSV‐1 infection with a high level of serum IgG antibody: Three case reports - Zakiawati - 2021 - Clinical Case Reports - Wiley Online Library
Herpes Simplex Virus 2 ICP0− Mutant Viruses Are Avirulent and Immunogenic: Implications for a Genital Herpes Vaccine | PLOS ONE
![A novel bioluminescent herpes simplex virus 1 for in vivo monitoring of herpes simplex encephalitis | Scientific Reports A novel bioluminescent herpes simplex virus 1 for in vivo monitoring of herpes simplex encephalitis | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-021-98047-z/MediaObjects/41598_2021_98047_Fig1_HTML.png)
A novel bioluminescent herpes simplex virus 1 for in vivo monitoring of herpes simplex encephalitis | Scientific Reports
![Frontiers | The Hippocampal Vulnerability to Herpes Simplex Virus Type I Infection: Relevance to Alzheimer's Disease and Memory Impairment Frontiers | The Hippocampal Vulnerability to Herpes Simplex Virus Type I Infection: Relevance to Alzheimer's Disease and Memory Impairment](https://www.frontiersin.org/files/Articles/695738/fncel-15-695738-HTML/image_m/fncel-15-695738-g001.jpg)
Frontiers | The Hippocampal Vulnerability to Herpes Simplex Virus Type I Infection: Relevance to Alzheimer's Disease and Memory Impairment
![Vaccines | Free Full-Text | Immune Response to Herpes Simplex Virus Infection and Vaccine Development | HTML Vaccines | Free Full-Text | Immune Response to Herpes Simplex Virus Infection and Vaccine Development | HTML](https://www.mdpi.com/vaccines/vaccines-08-00302/article_deploy/html/images/vaccines-08-00302-g001.png)
Vaccines | Free Full-Text | Immune Response to Herpes Simplex Virus Infection and Vaccine Development | HTML
![Infectious Disease Reports | Free Full-Text | Diagnosis of Herpes Simplex Virus: Laboratory and Point-of-Care Techniques | HTML Infectious Disease Reports | Free Full-Text | Diagnosis of Herpes Simplex Virus: Laboratory and Point-of-Care Techniques | HTML](https://www.mdpi.com/idr/idr-13-00049/article_deploy/html/images/idr-13-00049-g005.png)